QuidelOrtho Corporation Common Stock (QDEL)

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

QuidelOrtho Corporation Common Stock (QDEL) is listed on Nasdaq, where it has traded since August 4, 1981.

Listed On
Nasdaq
Listed Since
August 4, 1981
Employees
6,500
Market Cap
$750M

About QuidelOrtho Corporation Common Stock

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 237 institutions reported holding QDEL, with 83.0 million shares worth $1.5 billion in aggregate. The largest reported holder was BlackRock, with 11.2 million shares worth $196.2 million. Of the 5 largest holders listed below, all 5 added shares during the quarter.

InstitutionSharesValueQuarter change
BlackRock11,202,523$196MAdded 7.21%
Vanguard7,777,986$136MAdded 1.53%
FMR7,363,696$129MAdded 11.72%
Newtyn Management6,625,000$116MAdded 45.33%
Neuberger Berman Group3,534,619$62MAdded 130.96%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is QDEL?

QuidelOrtho Corporation Common Stock (QDEL) is listed on Nasdaq, where it has traded since August 4, 1981.

Who are the largest institutional holders of QDEL?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of QDEL were BlackRock, Vanguard and FMR.

How many institutions own QDEL?

237 institutions reported a position in QDEL for the quarter ended June 30, 2026, worth $1.5 billion in total.

Did institutions buy or sell QDEL last quarter?

Of the 5 largest reported holders, all 5 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for QDEL.

Every reported institutional holder, plus insider and congressional trades in QDEL, on SentiSense.